Human T-Cell Lymphotropic Virus Type 1 Open Reading Frame II-Encoded p30 II Is Required for In Vivo Replication: Evidence of In Vivo Reversion
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Human T-cell lymphotropic virus type 1 (HTLV-1) causes adult T-cell leukemia/lymphoma and exhibits high genetic stability in vivo. HTLV-1 contains four open reading frames (ORFs) in its pX region. ORF II encodes two proteins, p30 II and p13 II , both of which are incompletely characterized. p30 II localizes to the nucleus or nucleolus and has distant homology to the transcription factors Oct-1, Pit-1, and POU-M1. In vitro studies have demonstrated that at low concentrations, p30 II differentially regulates cellular and viral promoters through an interaction with CREB binding protein/p300. To determine the in vivo significance of p30 II , we inoculated rabbits with cell lines expressing either a wild-type clone of HTLV-1 (ACH.1) or a clone containing a mutation in ORF II, which eliminated wild-type p30 II expression (ACH.30.1). ACH.1-inoculated rabbits maintained higher HTLV-1-specific antibody titers than ACH.30.1-inoculated rabbits, and all ACH.1-inoculated rabbits were seropositive for HTLV-1, whereas only two of six ACH.30.1-inoculated rabbits were seropositive. Provirus could be consistently PCR amplified from peripheral blood mononuclear cell (PBMC) DNA in all ACH.1-inoculated rabbits but in only three of six ACH.30.1-inoculated rabbits. Quantitative competitive PCR indicated higher PBMC proviral loads in ACH.1-inoculated rabbits. Interestingly, sequencing of ORF II from PBMC of provirus-positive ACH.30.1-inoculated rabbits revealed a reversion to wild-type sequence with evidence of early coexistence of mutant and wild-type sequence. Our data provide evidence that HTLV-1 must maintain its key accessory genes to survive in vivo and that in vivo pressures select for maintenance of wild-type ORF II gene products during the early course of infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Berneman, Z. N., Gartenhaus, R. B., Reitz, M. S., Blattner, W. A., Manns, A., Hanchard, B., Ikehara, O., Gallo, R. C., & Klotman, M. E. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.3005 · Cited by 151
Infectious transmission of human T‐cell leukemia virus to rabbits
Miyoshi, I., Yoshimoto, S., Kubonishi, I., Fujishita, M., Ohtsuki, Y., Yamashita, M., Yamato, K., Hirose, S., Taguchi, H., Niiya, K., et al. (1985) · International Journal of Cancer · doi:10.1002/ijc.2910350113 · Cited by 72 · cited 1×
“HTLV-1 inoculation of the rabbit has been established as an appropriate model of persistent asymptomatic infection in humans (26).”
Background
Cited by
Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation
Matsuoka, M., & Jeang, K.-T. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2111 · Cited by 829
Gillet, N., Florins, A., Boxus, M., Burteau, C., Nigro, A., Vandermeers, F., Balon, H., Bouzar, A.-B., Defoiche, J., Burny, A., et al. (2007) · Retrovirology · doi:10.1186/1742-4690-4-18 · Cited by 398
Arnold, J., Yamamoto, B., Li, M., Phipps, A. J., Younis, I., Lairmore, M. D., & Green, P. L. (2006) · Blood · doi:10.1182/blood-2005-11-4551 · Cited by 196
Self-citationPreventive and Therapeutic Strategies for Bovine Leukemia Virus: Lessons for HTLV
Rodríguez, S. M., Florins, A., Gillet, N., De Brogniez, A., Sánchez-Alcaraz, M. T., Boxus, M., Boulanger, F., Gutiérrez, G., Trono, K., Alvarez, I., et al. (2011) · Viruses · doi:10.3390/v3071210 · Cited by 196
“Similar conclusions were drawn from HTLV mutant proviruses deleted in the ORFs encoding the p12 and p13/p30 orthologs of R3 and G4 [241–243].”
MethodMiyazaki, M., Yasunaga, J.-I., Taniguchi, Y., Tamiya, S., Nakahata, T., & Matsuoka, M. (2007) · Journal of Virology · doi:10.1128/jvi.02511-06 · Cited by 137
“These accessory genes are required for infectivity and for the persistence of HTLV-1 infection (1, 49).”
Background
Metadata
- Authors
- Silverman, L. R., Phipps, A. J., Montgomery, A., Ratner, L., & Lairmore, M. D.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2004-04-15
- Volume
- 78
- Issue
- 8
- Pages
- 3837-3845
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2120998555
- Cited by
- 84
- References
- 2
- FWCI
- 3.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Human T-Cell Lymphotropic Virus Type 1 Open Reading Frame II-Encoded p30 II Is Required for In Vivo Replication: Evidence of In Vivo Reversion. https://app.cochat.ai/papers/10.1128/jvi.78.8.3837-3845.2004
- The paper
- Silverman, L. R., Phipps, A. J., Montgomery, A., Ratner, L., & Lairmore, M. D. (2004). Human T-Cell Lymphotropic Virus Type 1 Open Reading Frame II-Encoded p30 II Is Required for In Vivo Replication: Evidence of In Vivo Reversion. Journal of Virology. https://doi.org/10.1128/jvi.78.8.3837-3845.2004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.